<!doctype html>
<html lang="en">
  <head>
    <meta charset="utf-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1" />
    <title>Lilly Moves Past 50-Day SMA: Should You Consider Buying the Stock Now?</title>
    <meta name="description" content="In 2025, Lilly expects to record revenues in the range of $60.0 billion to $62.0 billion, indicating an impressive year-over-year growth of more than 30% We believe that LLY has solid growth prospects and a promising por; Mounjaro and Zepbound account for around 50% of the company’s total revenues.; Lilly’s stock is up 18% since the second-quarter results, easing some of the recent negative sentiment." />
    <link rel="alternate" type="application/rss+xml" title="Daily Finance Newsletter" href="https://suavir600.github.io/newsletter/feed.xml" />
    <style>
:root{--bg:#0b0f19;--fg:#e8ecf2;--muted:#93a1b1;--card:#121826;--accent:#4f8cff}
*{box-sizing:border-box} body{margin:0;background:var(--bg);color:var(--fg);font:16px/1.55 system-ui,-apple-system,Segoe UI,Roboto,Ubuntu}
a{color:var(--accent);text-decoration:none} a:hover{text-decoration:underline}
.container{max-width:980px;margin:0 auto;padding:20px}
.nav{display:flex;align-items:center;justify-content:space-between;margin-bottom:20px}
.brand{font-weight:700} .muted{color:var(--muted)}
.grid{display:grid;grid-template-columns:repeat(auto-fill,minmax(280px,1fr));gap:16px}
.card{background:var(--card);border-radius:16px;padding:16px;box-shadow:0 6px 20px rgba(0,0,0,.25)}
.card h3{margin:0 0 8px 0;font-size:1.05rem}
.badge{display:inline-block;background:#1c2335;color:#c0cad8;padding:.2rem .5rem;border-radius:999px;font-size:.75rem;margin-right:.4rem}
.btn{display:inline-block;background:var(--accent);color:#fff;padding:.5rem .75rem;border-radius:10px;font-weight:600}
.btn-outline{background:transparent;border:1px solid var(--accent);color:var(--accent)}
.list ul{margin:.5rem 0 0 1.2rem}
.footer{margin-top:36px;color:var(--muted);font-size:.9rem;text-align:center}
hr{border:none;border-top:1px solid #223; margin:16px 0}
</style>
  </head>
  <body>
    <div class="container">
      <div class="nav">
        <div class="brand"><a href="https://suavir600.github.io/newsletter">Daily Finance Newsletter</a></div>
        <div class="muted">5–7 key bullets per story</div>
      </div>
      
<h1>Lilly Moves Past 50-Day SMA: Should You Consider Buying the Stock Now?</h1>
<div class="muted">2025-09-15 15:08:00+00:00</div>
<hr />
<div class="list"><ul>
  <li>In 2025, Lilly expects to record revenues in the range of $60.0 billion to $62.0 billion, indicating an impressive year-over-year growth of more than 30% We believe that LLY has solid growth prospects and a promising por</li><li>Mounjaro and Zepbound account for around 50% of the company’s total revenues.</li><li>Lilly’s stock is up 18% since the second-quarter results, easing some of the recent negative sentiment.</li><li>Competition Heating Up in the Obesity Space The obesity market is expected to expand to $100 billion by 2030, according to data from Goldman Sachs, which means fierce competition is inevitable.</li><li>In 2025, it announced three M&amp;A deals.</li><li>LLY’s Stock Price, Valuation and Estimates Lilly’s stock has declined 2.2% so far this year compared with the industry’s decrease of 0.2%.</li><li>In the ATTAIN-2 study in obese adults with type II diabetes, the highest dose (36 mg) of orforglipron delivered a weight loss of up to an average of 22.9 pounds or 10.5%.</li>
</ul></div>
<div style="margin-top:12px">
  <a class="btn-outline" href="https://finance.yahoo.com/news/lilly-moves-past-50-day-150800320.html" target="_blank" rel="noopener">Original</a>
  <a class="btn" href="https://twitter.com/intent/tweet?text=Lilly+Moves+Past+50-Day+SMA%3A+Should+You+Consider+Buying+the+Stock+Now%3F%0A%E2%80%A2+In+2025%2C+Lilly+expects+to+record+revenues+in+the+range+of+%2460.0+billion+to+%2462.0+billion%2C+indicating+an+impressive+year-over-year+growth+of+more+than+30%25+We+believe+that+LLY+has+sol%E2%80%A6%0Ahttps%3A%2F%2Fsuavir600.github.io%2Fnewsletter%2Farticles%2Flilly-moves-past-50-day-sma-should-you-consider-buying-the-stock-now%2F" target="_blank" rel="noopener">Share on X</a>
</div>

      <div class="footer">© 2025 · Built from digest_5bullets.md</div>
    </div>
  </body>
</html>